by Avril Tynan The progress and effectiveness of potential Covid–19 vaccines in the last few weeks have brought a new glimmer of hope to the closing months of 2020. While much of Europe remains under restrictions, or is tentatively emerging from a second lockdown, the new AstraZeneca-Oxford, BioNTech-Pfizer and Moderna vaccines are offering hope of […]